Richmond, Virginia, November 12, 2013 ? avVaa World Health Care Products' ("the Company") ("avVaa" or "the Company") (Pink Sheets: AVVH)
The company has just added 3 new products to its Neuroskin? branded catalog ? Anti-Aging Facial Cream, Pure Microdermabrasion, & High Intensity Moisturizer. These products are superior other products in the marketplace as they contain our patented biologically active silicon dioxide. This patented nanotechnology allows the silica to be broken down into a nano-particle level which allows it to be absorbed into the skin while maintaining its biologic properties.
Additionally, the company recently rolled out the new corporate branded Neuroskin? website www.neuroskin.com. The new website features a new fresh look with improved SEO capabilities to help improve the search rankings and support its ongoing online marketing campaign.
Avvaa Chairman & CEO states, "I am excited about bringing our patented nano-technology to the cosmetic skincare industry and look forward to adding more products to the catalog in the next couple of weeks. Furthermore, the introduction of the new Neuroskin? skincare line of products continues the commitment I have to bringing value to our shareholders".
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin? line of skin care products through mass food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.
Jason Price Chairman & CEO
avVaa World Health Care Products
P: 1-866-864-6598
E: jason.price@avvaa.com www.avvaa.com
Pink Sheets: AVVH
Safe Harbor
This news release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
The company has just added 3 new products to its Neuroskin? branded catalog ? Anti-Aging Facial Cream, Pure Microdermabrasion, & High Intensity Moisturizer. These products are superior other products in the marketplace as they contain our patented biologically active silicon dioxide. This patented nanotechnology allows the silica to be broken down into a nano-particle level which allows it to be absorbed into the skin while maintaining its biologic properties.
Additionally, the company recently rolled out the new corporate branded Neuroskin? website www.neuroskin.com. The new website features a new fresh look with improved SEO capabilities to help improve the search rankings and support its ongoing online marketing campaign.
Avvaa Chairman & CEO states, "I am excited about bringing our patented nano-technology to the cosmetic skincare industry and look forward to adding more products to the catalog in the next couple of weeks. Furthermore, the introduction of the new Neuroskin? skincare line of products continues the commitment I have to bringing value to our shareholders".
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin? line of skin care products through mass food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.
Jason Price Chairman & CEO
avVaa World Health Care Products
P: 1-866-864-6598
E: jason.price@avvaa.com www.avvaa.com
Pink Sheets: AVVH
Safe Harbor
This news release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.